Garr will present a business overview, including a first look at the Phase I/II Stroke/NSI-566 cell therapy trial expected to commence in within several weeks.
http://www.drugs.com/clinical_trials/neuralstem-president-ceo-present-2013-trials-overview-2013-biotech-showcase-14997.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
http://www.drugs.com/clinical_trials/neuralstem-president-ceo-present-2013-trials-overview-2013-biotech-showcase-14997.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
No comments:
Post a Comment